======= B3GALT4 ======= == Gene Information == * **Official Symbol**: B3GALT4 * **Official Name**: beta-1,3-galactosyltransferase 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8705|8705]] * **UniProt**: [[https://www.uniprot.org/uniprot/O96024|O96024]] * **Interactions**: [[https://thebiogrid.org/search.php?search=B3GALT4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20B3GALT4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603095|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Involved in GM1/GD1B/GA1 ganglioside biosynthesis. {ECO:0000269|PubMed:9582303}. |Galactosyl T| |ganglioside galactosyltransferase activity| |UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity| |ganglioside biosynthetic process| |ganglioside metabolic process| |acetylgalactosaminyltransferase activity| |glycosphingolipid biosynthetic process| |ceramide biosynthetic process| |glycolipid biosynthetic process| |glycosphingolipid metabolic process| |ceramide metabolic process| |sphingolipid biosynthetic process| |glycolipid metabolic process| |liposaccharide metabolic process| |membrane lipid biosynthetic process| |sphingolipid metabolic process| |membrane lipid metabolic process| |protein glycosylation| |macromolecule glycosylation| |glycosylation| |glycoprotein biosynthetic process| |glycoprotein metabolic process| |amide biosynthetic process| |lipid biosynthetic process| |carbohydrate derivative biosynthetic process| |Golgi membrane| |cellular amide metabolic process| |cellular lipid metabolic process| |Golgi apparatus| |endoplasmic reticulum| |carbohydrate derivative metabolic process| |lipid metabolic process| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|-2.03| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.82| |[[:results:exp145|PNU96415E 10μM R03 exp145]]|-1.78| |[[:results:exp406|Thalidomide 20μM R07 exp406]]|1.81| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.526| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4604 * **Expression level (log2 read counts)**: 1.72 {{:chemogenomics:nalm6 dist.png?nolink |}}